Residual Vein Obstruction Down With Compression After DVT

RVO less likely for those receiving compression within 24 hours of diagnosis of deep vein thrombosis
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Cardiology, Internal Medicine, Pulmonology, Journal, Source Type: news

Related Links:

DiscussionSingle use of IPC device could not reach significant level of DVT prophylaxis compared to control group and only chemoprophylaxis showed significantly reduce the incidence of overall DVT following TKA. Single use of IPC device does not show effective thromboprophylaxis in a low DVT incidence population.Level of evidenceIII, case control study.
Source: Orthopaedics and Traumatology: Surgery and Research - Category: Orthopaedics Source Type: research
Conclusions19% of all patients treated by platinum-based chemotherapy due to testicular cancer suffered from a venous thromboembolic event, associated with reduced overall survival. As a result, monitoring of cancer patients at risk as well as the improvement of patients ’ awareness of a thromboembolic event should thus be the main goal of their treating physicians.
Source: World Journal of Urology - Category: Urology & Nephrology Source Type: research
This study investigated if statins would similarly reduce postoperative arrhythmias in patients undergoing THA. METHODS:: We queried a large Medicare and private-payer database from 2005 to 2012 and identified 12,075 patients who were on a statin prior to THA. We then age and sex matched 34,446 non-statin users who underwent THA. Baseline comorbidities and postoperative complications were obtained and assessed via standard descriptive statistics. RESULTS:: The statin users had more preoperative comorbidities including congestive heart failure, valvular heart disease, pulmonary and renal disease, diabetes, hyperte...
Source: Hip International - Category: Orthopaedics Authors: Tags: Hip Int Source Type: research
Authors: Keramida K, Lazaros G, Nihoyannopoulos P Abstract Although hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy worldwide, the criteria for its definition and most of the literature concern the left ventricle, confirming the theory that the right ventricle is the neglected one. Right ventricular (RV) involvement includes structural and functional changes with significant impact on clinical presentation and prognosis. The pattern of RV hypertrophy can be variable with possible dynamic obstruction. Histological findings suggest similar pathogenetic changes in both ventricles supporti...
Source: Hellenic Journal of Cardiology - Category: Cardiology Tags: Hellenic J Cardiol Source Type: research
Data regarding the use of direct oral anticoagulants (DOACs) for the treatment of acute pulmonary embolism (PE) are sparse. We conducted a prospective multicentre registry study to describe patterns of DOAC prescription for the treatment of acute PE, and the associated risk of 6-month adverse events in daily practice.
Source: Thrombosis Research - Category: Hematology Authors: Tags: Full Length Article Source Type: research
We present a novel, life-threatening complication: an acute, noninfectious TPV thrombosis. Within 24 hours after implantation of a Melody system (Medtronic, Inc, Minneapolis, MN), the patient developed an acute TPV thrombosis characterized by severe TPV stenosis on echocardiography and contrast filling defects on computed tomography pulmonary angiography images. Genetic testing revealed heterozygous prothrombin G20210A polymorphism and homozygous 4G/4G polymorphism of the plasminogen-activator-inhibitor. The patient recovered after surgical valve replacement with a pulmonary homograft.RésuméLe remplacement de...
Source: Canadian Journal of Cardiology - Category: Cardiology Source Type: research
Atherosclerosis is associated with increased cardiovascular mortality. Associations between venous thromboembolism and atherosclerosis were recently reported. We aimed to investigate the impact of symptomatic atherosclerosis on adverse outcomes in patients with pulmonary embolism (PE) and to identify significant differences among patients with PE stratified by symptomatic atherosclerosis.
Source: International Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Protein S (PS, OMIM #176880) is a vitamin K-dependent plasma glycoprotein that acts as a non-enzymatic cofactor for activated protein C (PC) involved in the degradation of coagulation factors V and VIII, thereby inhibiting blood clotting [1]. PS deficiency (PSD, OMIM#612336) is an autosomal dominant (AD) haploinsufficiency disorder with incomplete penetrance and variable clinical expressivity, recognized as an independent risk factor for venous thromboembolism (VTE) and found in 1.5% to 7% of selected groups of thrombophilic patients [2].
Source: Thrombosis Research - Category: Hematology Authors: Tags: Letter to the Editors-in-Chief Source Type: research
The incidence, risk factors, clinical presentation, and prognosis of cardiovascular diseases differ among men and women [1,2]. Defining, measuring, understanding and responding to these differences is important in an era of individualized and precision medicine. Sex specific differences in the incidence of venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), have long been recognized. Women are at higher risk during fertile years, mainly due to the effects of pregnancy and oral contraceptive use [3], and men are at higher risk at older ages [4].
Source: Thrombosis Research - Category: Hematology Authors: Tags: Editorial Source Type: research
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) affect>200 000 individuals yearly with a 40% mortality rate. Although platelets are implicated in the progression of ALI/ARDS, their exact role remains undefined. Triggering receptor expressed in myeloid cells (TREM)–like transcript 1 (TLT-1) is found on platelets, binds fibrinogen, and mediates clot formation. We hypothesized that platelets use TLT-1 to manage the progression of ALI/ARDS. Here we retrospectively measure plasma levels of soluble TLT-1 (sTLT-1) from the ARDS Network clinical trial and show that patients whose sTLT-1 levels were&...
Source: Blood - Category: Hematology Authors: Tags: Immunobiology and Immunotherapy, Phagocytes, Granulocytes, and Myelopoiesis, Platelets and Thrombopoiesis, Thrombosis and Hemostasis Source Type: research
More News: Cardiology | Heart | Internal Medicine | Pulmonary Thromboembolism | Respiratory Medicine | Thrombosis